Page 6 of 8 · 175 questions tagged glp1-mechanism.
Conditions: semaglutide · SELECT. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
I would like to know how much of this is established and how much is a reasonable story. I understand the observation; what I do not understand is the mechanism…
What I have: 30 mg · dulaglutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
Details up front: cagrilintide · five days. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
Numbers first: a GLP-1 receptor agonist · PIONEER-1. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
Concretely: survodutide · twenty-eight days. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is…
Conditions: semaglutide · PIONEER-1. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
What I am working with: orforglipron · PIONEER-1. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
Stated plainly: dulaglutide · FLOW. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear that…
What I am working with: 5 mg · cagrilintide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My background…
Setup, so nobody has to ask: 60 mg · cagrilintide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
For reference: tirzepatide · ten days. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that…
Numbers first: a GLP-1 receptor agonist · TRIUMPH-1. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
For reference: 50 mg · survodutide. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to reason…
What I have: 2 mg · dulaglutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
Concretely: ecnoglutide · seven days. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because…
I keep a written log of every draw with date, volume and syringe type. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may…
Conditions: semaglutide · STEP 5. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because it…
The specifics, since they change the answer: liraglutide · forty-two days. I would like the mechanism, because I want to be able to reason about the cases nobody has…
Stated plainly: 5 mg · mazdutide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear that…
Stated plainly: retatrutide · PIONEER-1. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear…
Numbers first: mazdutide · SUSTAIN-6. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
Stated plainly: dulaglutide · TRIUMPH-3. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My background is…
The receptor pharmacology I can follow; the in vivo translation is where I lose the thread. I would like the axes of comparison first and the recommendation second. I…